Bronchopulmonary Dysplasia: Executive Summary of a Workshop

[1]  J. Mugler,et al.  Hyperpolarized Helium-3 Diffusion-weighted Magnetic Resonance Imaging Detects Abnormalities of Lung Structure in Children With Bronchopulmonary Dysplasia , 2017, Journal of thoracic imaging.

[2]  R. Clyman,et al.  Prophylactic Indomethacin Compared with Delayed Conservative Management of the Patent Ductus Arteriosus in Extremely Preterm Infants: Effects on Neonatal Outcomes. , 2017, The Journal of pediatrics.

[3]  P. Shaw,et al.  Bronchopulmonary Dysplasia and Perinatal Characteristics Predict 1-Year Respiratory Outcomes in Newborns Born at Extremely Low Gestational Age: A Prospective Cohort Study. , 2017, The Journal of pediatrics.

[4]  B. Poindexter,et al.  Antenatal Determinants of Bronchopulmonary Dysplasia and Late Respiratory Disease in Preterm Infants , 2017, American journal of respiratory and critical care medicine.

[5]  B. Poindexter,et al.  Association between Use of Prophylactic Indomethacin and the Risk for Bronchopulmonary Dysplasia in Extremely Preterm Infants , 2017, The Journal of pediatrics.

[6]  L. Doyle,et al.  Academic Performance, Motor Function, and Behavior 11 Years After Neonatal Caffeine Citrate Therapy for Apnea of Prematurity: An 11-Year Follow-up of the CAP Randomized Clinical Trial , 2017, JAMA pediatrics.

[7]  Ji Hye Kim,et al.  Two‐Year Follow‐Up Outcomes of Premature Infants Enrolled in the Phase I Trial of Mesenchymal Stem Cells Transplantation for Bronchopulmonary Dysplasia , 2017, The Journal of pediatrics.

[8]  Jeffrey S. Buzas,et al.  Variation in Performance of Neonatal Intensive Care Units in the United States , 2017, JAMA pediatrics.

[9]  Shoo K. Lee,et al.  Revisiting the Definition of Bronchopulmonary Dysplasia: Effect of Changing Panoply of Respiratory Support for Preterm Neonates , 2017, JAMA pediatrics.

[10]  J. Feinstein,et al.  Evaluation and Management of Pulmonary Hypertension in Children with Bronchopulmonary Dysplasia , 2017, The Journal of pediatrics.

[11]  Sean B Fain,et al.  Pulmonary MRI of neonates in the intensive care unit using 3D ultrashort echo time and a small footprint MRI system , 2017, Journal of magnetic resonance imaging : JMRI.

[12]  M. Keszler,et al.  Interdisciplinary Care of Children with Severe Bronchopulmonary Dysplasia , 2017, The Journal of pediatrics.

[13]  B. Thébaud,et al.  Cell Therapy for Bronchopulmonary Dysplasia: Promises and Perils. , 2016, Paediatric respiratory reviews.

[14]  J. Beyene,et al.  Association of Noninvasive Ventilation Strategies With Mortality and Bronchopulmonary Dysplasia Among Preterm Infants: A Systematic Review and Meta-analysis. , 2016, JAMA.

[15]  R. Polin,et al.  Oxygen Targeting in Extremely Low Birth Weight Infants , 2016, Pediatrics.

[16]  D. Mohamed,et al.  Effect of early low-dose hydrocortisone on survival without bronchopulmonary dysplasia in extremely preterm infants (PREMILOC): a double-blind, placebo-controlled, multicentre, randomised trial , 2016, The Lancet.

[17]  B. Poindexter,et al.  Comparisons and Limitations of Current Definitions of Bronchopulmonary Dysplasia for the Prematurity and Respiratory Outcomes Program. , 2015, Annals of the American Thoracic Society.

[18]  Jean A. Tkach,et al.  Quantitative Magnetic Resonance Imaging of Bronchopulmonary Dysplasia in the Neonatal Intensive Care Unit Environment. , 2015, American journal of respiratory and critical care medicine.

[19]  C. Meisner,et al.  Early Inhaled Budesonide for the Prevention of Bronchopulmonary Dysplasia. , 2015, The New England journal of medicine.

[20]  M. Wickman,et al.  Lung function at 6 and 18 months after preterm birth in relation to severity of bronchopulmonary dysplasia , 2015, Pediatric pulmonology.

[21]  M. Walsh,et al.  Trends in Care Practices, Morbidity, and Mortality of Extremely Preterm Neonates, 1993-2012. , 2015, JAMA.

[22]  T. Mariani,et al.  Prematurity and respiratory outcomes program (PROP): study protocol of a prospective multicenter study of respiratory outcomes of preterm infants in the United States , 2015, BMC Pediatrics.

[23]  J. Ellenberg,et al.  Respiratory consequences of prematurity: evolution of a diagnosis and development of a comprehensive approach , 2015, Journal of Perinatology.

[24]  M. Walsh,et al.  Respiratory outcomes of the surfactant positive pressure and oximetry randomized trial (SUPPORT). , 2014, The Journal of pediatrics.

[25]  M. Meyer,et al.  Randomized controlled trial of oxygen saturation targets in very preterm infants: two year outcomes. , 2014, The Journal of pediatrics.

[26]  A. Buist,et al.  Vitamin C supplementation for pregnant smoking women and pulmonary function in their newborn infants: a randomized clinical trial. , 2014, JAMA.

[27]  Hye Soo Yoo,et al.  Mesenchymal stem cells for bronchopulmonary dysplasia: phase 1 dose-escalation clinical trial. , 2014, The Journal of pediatrics.

[28]  N. Marlow,et al.  Late outcomes of a randomized trial of high-frequency oscillation in neonates. , 2014, The New England journal of medicine.

[29]  E. Jensen,et al.  Epidemiology of bronchopulmonary dysplasia. , 2014, Birth defects research. Part A, Clinical and molecular teratology.

[30]  H. Fischer,et al.  Avoiding Endotracheal Ventilation to Prevent Bronchopulmonary Dysplasia: A Meta-analysis , 2013, Pediatrics.

[31]  R. Harding,et al.  Impact of preterm birth and bronchopulmonary dysplasia on the developing lung: Long‐term consequences for respiratory health , 2013, Clinical and experimental pharmacology & physiology.

[32]  B. Thébaud,et al.  Stem cell-based therapy for neonatal lung disease—it’s in the juice , 2013, Pediatric Research.

[33]  P. Mourani,et al.  Pulmonary vascular disease in bronchopulmonary dysplasia: pulmonary hypertension and beyond , 2013, Current opinion in pediatrics.

[34]  M. Meyer,et al.  Oxygen saturation and outcomes in preterm infants. , 2013, The New England journal of medicine.

[35]  B. Schmidt,et al.  Effects of targeting higher vs lower arterial oxygen saturations on death or disability in extremely preterm infants: a randomized clinical trial. , 2013, JAMA.

[36]  N. Marlow,et al.  Respiratory morbidity at follow-up of small-for-gestational-age infants born very prematurely , 2013, Pediatric Research.

[37]  B. Poindexter,et al.  Neurodevelopmental outcomes in the early CPAP and pulse oximetry trial. , 2012, The New England journal of medicine.

[38]  A. Jefferies.  Postnatal corticosteroids to treat or prevent chronic lung disease in preterm infants. , 2012, Paediatrics & child health.

[39]  P. Mondéjar-López,et al.  Lung function among infants born preterm, with or without bronchopulmonary dysplasia , 2012, Pediatric pulmonology.

[40]  J. Kaempf,et al.  What happens when the patent ductus arteriosus is treated less aggressively in very low birth weight infants? , 2012, Journal of Perinatology.

[41]  K. de Waal,et al.  The definition of a haemodynamic significant duct in randomized controlled trials: a systematic literature review , 2012, Acta paediatrica.

[42]  L. Doyle,et al.  Survival without disability to age 5 years after neonatal caffeine therapy for apnea of prematurity. , 2012, Journal of the American Medical Association (JAMA).

[43]  B. Poindexter,et al.  Association of antenatal corticosteroids with mortality and neurodevelopmental outcomes among infants born at 22 to 25 weeks' gestation. , 2011, JAMA.

[44]  B. Schmidt,et al.  NeOProM: Neonatal Oxygenation Prospective Meta-analysis Collaboration study protocol , 2011, BMC pediatrics.

[45]  W. Künzel,et al.  Impact of fetal growth restriction on mortality and morbidity in a very preterm birth cohort. , 2010, The Journal of pediatrics.

[46]  B. Mol,et al.  Effects of Antenatal Corticosteroids Given Prior to 26 Weeks' Gestation: A Systematic Review of Randomized Controlled Trials , 2010, American journal of perinatology.

[47]  Abhik Das,et al.  Early CPAP versus surfactant in extremely preterm infants. , 2010, The New England journal of medicine.

[48]  B. Poindexter,et al.  Target ranges of oxygen saturation in extremely preterm infants. , 2010, The New England journal of medicine.

[49]  L. Doyle,et al.  Late (>7 days) postnatal corticosteroids for chronic lung disease in preterm infants. , 2009, The Cochrane database of systematic reviews.

[50]  D. McElhinney,et al.  Pulmonary Artery Hypertension in Formerly Premature Infants With Bronchopulmonary Dysplasia: Clinical Features and Outcomes in the Surfactant Era , 2007, Pediatrics.

[51]  L. Doyle,et al.  Long-term effects of caffeine therapy for apnea of prematurity. , 2007, The New England journal of medicine.

[52]  S. Kazzi,et al.  A Cluster-Randomized Trial of Benchmarking and Multimodal Quality Improvement to Improve Rates of Survival Free of Bronchopulmonary Dysplasia for Infants With Birth Weights of Less Than 1250 Grams , 2007, Pediatrics.

[53]  Julie Brown,et al.  Antenatal Corticosteroids for Accelerating Fetal Lung Maturation for Women at Risk of Preterm Birth , 2007, The Cochrane database of systematic reviews.

[54]  L. Doyle,et al.  Caffeine therapy for apnea of prematurity. , 2006, The New England journal of medicine.

[55]  B. Vohr,et al.  Vitamin A Supplementation for Extremely Low Birth Weight Infants: Outcome at 18 to 22 Months , 2005, Pediatrics.

[56]  M. Walsh,et al.  Impact of a Physiologic Definition on Bronchopulmonary Dysplasia Rates , 2004, Pediatrics.

[57]  L. Irwig,et al.  Oxygen-saturation targets and outcomes in extremely preterm infants. , 2003, The New England journal of medicine.

[58]  M. Walsh,et al.  Safety, Reliability, and Validity of a Physiologic Definition of Bronchopulmonary Dysplasia , 2003, Journal of Perinatology.

[59]  J. Davis,et al.  Pulmonary outcome at 1 year corrected age in premature infants treated at birth with recombinant human CuZn superoxide dismutase. , 2003, Pediatrics.

[60]  E. Bancalari,et al.  Bronchopulmonary dysplasia: changes in pathogenesis, epidemiology and definition. , 2003, Seminars in neonatology : SN.

[61]  N. Marlow,et al.  High-frequency oscillatory ventilation for the prevention of chronic lung disease of prematurity. , 2002, The New England journal of medicine.

[62]  W. Poole,et al.  Late-onset sepsis in very low birth weight neonates: the experience of the NICHD Neonatal Research Network. , 2002, Pediatrics.

[63]  Stark Ar.  超出生体重児に対する早期デキサメサゾン投与の有用性 : National Institute of Child Health and Human Development Neonatal research Network報告 (海外誌掲載論文の和文概要とそれに対するコメント) , 2001 .

[64]  J. Flynn,et al.  Supplemental Therapeutic Oxygen for Prethreshold Retinopathy Of Prematurity (STOP-ROP), a randomized, controlled trial. I: primary outcomes. , 2000, Pediatrics.

[65]  D. J. Goldstein,et al.  Randomized Placebo-controlled Trial of a 42-Day Tapering Course of Dexamethasone to Reduce the Duration of Ventilator Dependency in Very Low Birth Weight Infants: Outcome of Study Participants at 1-Year Adjusted Age , 1999, Pediatrics.

[66]  J. Tyson,et al.  VITAMIN A SUPPLEMENTATION FOR EXTREMELY-LOW-BIRTH-WEIGHT INFANTS , 1999 .

[67]  A. Ohlsson,et al.  Abnormal pulmonary outcomes in premature infants: prediction from oxygen requirement in the neonatal period. , 1988, Pediatrics.

[68]  D. S. Brudno,et al.  Controlled trial of dexamethasone in respirator-dependent infants with bronchopulmonary dysplasia. , 1985, Pediatrics.

[69]  M. Durand,et al.  Tidal volume and respiratory frequency in infants with bronchopulmonary dysplasia (BPD). , 1981, Early human development.

[70]  A. Philip.  Oxygen plus pressure plus time: the etiology of bronchopulmonary dysplasia. , 1975, Pediatrics.

[71]  W. Northway,et al.  Pulmonary disease following respirator therapy of hyaline-membrane disease. Bronchopulmonary dysplasia. , 1967, The New England journal of medicine.

[72]  C. McEvoy,et al.  Pulmonary Effects of Maternal Smoking on the Fetus and Child: Effects on Lung Development, Respiratory Morbidities, and Life Long Lung Health. , 2017, Paediatric respiratory reviews.

[73]  T. Yeh,et al.  Intratracheal Administration of Budesonide/Surfactant to Prevent Bronchopulmonary Dysplasia. , 2016, American journal of respiratory and critical care medicine.

[74]  B. Poindexter,et al.  Early pulmonary vascular disease in preterm infants at risk for bronchopulmonary dysplasia. , 2015, American journal of respiratory and critical care medicine.

[75]  D. Phelps.  Supplemental Therapeutic Oxygen for Prethreshold Retinopathy of Prematurity (STOP-ROP), A Randomized, Controlled Trial. I: Primary Outcomes , 2013 .

[76]  Postnatal corticosteroids to treat or prevent chronic lung disease in preterm infants. , 2002, Paediatrics & child health.

[77]  E. Bancalari,et al.  Bronchopulmonary dysplasia. , 2001, American journal of respiratory and critical care medicine.

[78]  J. Flynn,et al.  On "supplemental therapeutic oxygen for prethreshold retinopathy of prematurity (STOP-ROP), a randomized, controlled trial. I: Primary outcomes". , 2000, Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus.

[79]  R. Ehrenkranz,et al.  Vitamin A supplementation for extremely-low-birth-weight infants. National Institute of Child Health and Human Development Neonatal Research Network. , 1999, New England Journal of Medicine.

[80]  Edinburgh Research Explorer Outcomes of Two Trials of Oxygen-Saturation Targets in Preterm Infants , 2022 .